Ugandan Leader Signs `Life Presidency' Legislation Into Law
(Bloomberg) -- Ugandan President Yoweri Museveni signed a controversial law that abolishes an age limit of 75 for candidates seeking to lead the country, positioning him to potentially extend his three-decade rule.
“He assented to the enactment and it now becomes law,” presidential spokesman Don Wanyama said by phone from the capital, Kampala.
Museveni, 73, signed the legislation on Dec. 27, Wanyama said. He can now vie for a sixth elected term in 2021. The former guerilla leader has been in power since 1986 and only Teodoro Obiang Nguema of Equatorial Guinea, Paul Biya of Cameroon and Denis Sassou Nguesso of the Republic of Congo have led their nations for longer.
Opposition lawmakers and civil society group protested against the bill that was passed by a majority of lawmakers in parliament a week before Museveni signed it. Parliament also approved a seven-year tenure for lawmakers from five years, starting with the current term.
“It sets a bad precedent for the country, what Ugandans need is not a life presidency,” said Livingstone Sewanyana, executive director of Kampala-based Foundation for Human Rights Initiative. “We are not surprised by his assent to the bill because it was largely his scheme.”
Museveni has defended the constitutional change, saying it would help ease what he called a leadership crisis in Africa. Age limits deny the population the right to choose their leaders, he said.
To contact the reporter on this story: Fred Ojambo in Kampala at fojambo@bloomberg.net.
To contact the editors responsible for this story: Paul Richardson at pmrichardson@bloomberg.net, Helen Nyambura, Rene Vollgraaff
©2018 Bloomberg L.P.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.